|
Coagulation and fibronolysis
Citations 1-10 of 46 total displayed.
|
Most recent content
(1 Sep 2009):
|
- Original Contributions
Migraine and Biomarkers of Endothelial Activation in Young Women
- Gretchen E. Tietjen, Nabeel A. Herial, Leah White, Christine Utley, Janet M. Kosmyna, and Sadik A. Khuder
Stroke 2009;40:2977-2982; published online before print as doi:10.1161/STROKEAHA.109.547901
[Abstract]
[Full text]
|
Past content
(since Oct 1999):
|
- Articles
Migraine and Biomarkers of Endothelial Activation in Young Women
- Gretchen E. Tietjen, Nabeel A. Herial, Leah White, Christine Utley, Janet M. Kosmyna, and Sadik A. Khuder
Stroke published July 16, 2009, doi:10.1161/STROKEAHA.109.547901
[Abstract]
- Original Contributions
Can a Subset of Intracerebral Hemorrhage Patients Benefit From Hemostatic Therapy With Recombinant Activated Factor VII?
- Stephan A. Mayer, Stephen M. Davis, Brett E. Skolnick, Nikolai C. Brun, Kamilla Begtrup, Joseph P. Broderick, Michael N. Diringer, and Thorsten Steiner
Stroke 2009;40:833-840; published online before print as doi:10.1161/STROKEAHA.108.524470
[Abstract]
[Full text]
- Articles
Can a Subset of Intracerebral Hemorrhage Patients Benefit From Hemostatic Therapy With Recombinant Activated Factor VII?
- Stephan A. Mayer, Stephen M. Davis, Brett E. Skolnick, Nikolai C. Brun, Kamilla Begtrup, Joseph P. Broderick, Michael N. Diringer, and Thorsten Steiner
Stroke published January 15, 2009, doi:10.1161/STROKEAHA.108.524470
[Abstract]
- Research Letters
Change in Hemostatic Markers After Recombinant Tissue-Type Plasminogen Activator Is Not Associated With the Chance of Recanalization
- Joan Martí-Fàbregas, Montserrat Borrell, Dolores Cocho, Sergi Martínez-Ramírez, Mercè Martínez-Corral, Jordi Fontcuberta, and Josep-Lluis Martí-Vilalta
Stroke 2008;39:234-236; published online before print as doi:10.1161/STROKEAHA.107.493767
[Abstract]
[Full text]
- Articles
Change in Hemostatic Markers After Recombinant Tissue-Type Plasminogen Activator Is Not Associated With the Chance of Recanalization
- Joan Martí-Fàbregas, Montserrat Borrell, Dolores Cocho, Sergi Martínez-Ramírez, Mercè Martínez-Corral, Jordi Fontcuberta, and Josep-Lluis Martí-Vilalta
Stroke published November 29, 2007, doi:10.1161/STROKEAHA.107.493767
[Abstract]
- Original Contributions
Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
- David Tanne, Richard F. Macko, Yan Lin, Barbara C. Tilley, Steven R. Levine for the NINDS rtPA Stroke Study Group
Stroke 2006;37:1798-1804; published online before print as doi:10.1161/01.STR.0000226897.43749.27
[Abstract]
[Full text]
- Articles
Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
- David Tanne, Richard F. Macko, Yan Lin, Barbara C. Tilley, Steven R. Levine for the NINDS rtPA Stroke Study Group
Stroke published June 8, 2006, doi:10.1161/01.STR.0000226897.43749.27
[Abstract]
- Editorials
Lipoprotein(a): Involved in Events, but Not Burden of Atherosclerotic Disease?
- J. David Spence
Stroke 2006;37:1350-1351; published online before print as doi:10.1161/01.STR.0000222979.34697.bf
[Full text]
- Original Contributions
Lipoprotein(a) and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
- Tetsuya Ohira, Pamela J. Schreiner, Joel D. Morrisett, Lloyd E. Chambless, Wayne D. Rosamond, and Aaron R. Folsom
Stroke 2006;37:1407-1412; published online before print as doi:10.1161/01.STR.0000222666.21482.b6
[Abstract]
[Full text]
|
|
